BioTech Weekly - Aug 11-17, 2025 (Week 33)

🚀 Biotech & Life Sciences – Latest Highlights

🔹 VivoSim Labs Appoints Tony Lialin as Chief Commercial Officer

🔹 Enveric Biosciences Reports Second Quarter 2025 Financial and Corporate Results

🔹 Allonnia and Eagle Mine Partner to Deploy D-Solve™ Technology to Unlock More Nickel

🔹 Cannara Biotech Enhances Financial Flexibility Through Strategic Asset Sale

🔹 Medidata Accelerates Business Transformation with Lisa Moneymaker as Chief Strategy Officer

🔹 Ousted FDA vaccine chief Vinay Prasad is returning to the agency

🔹 Quantum BioPharma Signs Agreement to Manufacture Oral Drug Formulation of Lucid-MS

🔹 BinSentry Raises $50 Million to Modernize Animal Feed Supply Chains

🔹 Quantum BioPharma Announces Promising PET Tracer Results for MS Patients

🔹 PharmAla Delivers MDMA to Merhavim Mental Health Centre Clinical Trial

🔹 Oncomatryx Biopharma Awarded €12.5 Million EIC Accelerator Funding

🔹 Optogenetic platform enables precise discovery of anti-aging therapeutics

🌍 From neuropsychiatry breakthroughs to advanced toxicology models, oncology innovations, sustainable mining, and next-gen biotech platforms—the sector is moving fast.

✨ Which of these innovations do you think will have the biggest impact in the next 5 years?

#Biotech #LifeSciences #Pharma #AgTech #HealthcareInnovation #ClinicalTrials #DrugDevelopment #Sustainability #NeurodegenerativeDiseases #Oncology #AIinHealthcare #MedTech